Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$381.09 - $495.99 $405,098 - $527,237
1,063 Added 27.1%
4,986 $2.26 Million
Q1 2024

May 13, 2024

BUY
$308.3 - $463.55 $593,477 - $892,333
1,925 Added 96.35%
3,923 $1.82 Million
Q4 2023

Feb 13, 2024

SELL
$289.29 - $409.7 $37,607 - $53,261
-130 Reduced 6.11%
1,998 $756,000
Q3 2023

Nov 13, 2023

BUY
$401.2 - $581.79 $239,516 - $347,328
597 Added 38.99%
2,128 $879,000
Q2 2023

Aug 04, 2023

BUY
$500.0 - $659.0 $47,000 - $61,946
94 Added 6.54%
1,531 $866,000
Q1 2023

May 11, 2023

SELL
$565.0 - $694.87 $32,770 - $40,302
-58 Reduced 3.88%
1,437 $902,000
Q4 2022

Feb 07, 2023

BUY
$551.1 - $688.5 $823,894 - $1.03 Million
1,495 New
1,495 $836,000
Q1 2021

May 04, 2021

SELL
$619.2 - $736.0 $214,862 - $255,392
-347 Closed
0 $0
Q4 2020

Feb 02, 2021

BUY
$576.6 - $672.2 $576 - $672
1 Added 0.29%
347 $223,000
Q3 2020

Oct 09, 2020

SELL
$620.1 - $689.89 $35,965 - $40,013
-58 Reduced 14.36%
346 $216,000
Q2 2020

Jul 08, 2020

BUY
$610.05 - $713.9 $57,344 - $67,106
94 Added 30.32%
404 $257,000
Q1 2020

Apr 23, 2020

SELL
$615.5 - $751.4 $46,162 - $56,355
-75 Reduced 19.48%
310 $202,000
Q4 2019

Feb 11, 2020

SELL
$688.5 - $846.15 $12,393 - $15,230
-18 Reduced 4.47%
385 $289,000
Q3 2019

Oct 17, 2019

BUY
$722.04 - $840.0 $58,485 - $68,040
81 Added 25.16%
403 $314,000
Q2 2019

Aug 02, 2019

BUY
$837.83 - $927.0 $25,134 - $27,810
30 Added 10.27%
322 $275,000
Q1 2019

May 10, 2019

SELL
$709.9 - $885.4 $8,518 - $10,624
-12 Reduced 3.95%
292 $257,000
Q4 2018

Feb 13, 2019

BUY
$667.94 - $785.7 $203,053 - $238,852
304 New
304 $225,000
Q3 2018

Nov 14, 2018

SELL
$602.8 - $699.6 $1,808 - $2,098
-3 Closed
0 $0
Q1 2018

May 09, 2018

BUY
$526.8 - $633.85 $526 - $633
1 Added 50.0%
3 $2,000
Q4 2017

Feb 20, 2018

BUY
$620.6 - $689.35 $1,241 - $1,378
2
2 $1,000

Others Institutions Holding ATRI

About ATRION CORP


  • Ticker ATRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 1,785,990
  • Description
  • Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in vari...
More about ATRI
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.